Actively Recruiting
Study of Antibiotic Effects on Blood Bacteria Clearance in Murine and Scrub Typhus Patients Using Doxycycline and Azithromycin
Led by Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit · Updated on 2026-10-13
72
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying murine typhus and scrub typhus, diseases caused by bacteria transmitted by fleas and mites, respectively. These infections are difficult to diagnose and can vary widely in severity and mortality. The trial aims to understand how quickly these bacteria clear from the blood after treatment and to compare the effectiveness of two antibiotics, doxycycline and azithromycin, in treating these infections. Participants will receive either doxycycline, starting with a 200 mg loading dose followed by 100 mg every 12 hours for 3 days, or azithromycin, starting with a 500 mg loading dose followed by 250 mg daily for 2 days, then followed by 3 days of doxycycline. These treatments are given orally during the hospital stay. The study uses a randomized, parallel design to compare these two antibiotic regimens for murine typhus or scrub typhus. During the study, participants will have blood samples taken to measure bacterial clearance using PCR testing and to monitor drug levels in plasma and inside blood cells over time. Researchers will track fever resolution, adverse events, and evaluate diagnostic tests for accuracy. Follow-up visits will assess response to treatment and safety for up to 28 days. Total participation includes hospital stay and follow-up visits as scheduled by the study team.
CONDITIONS
Brief Title
Rickettsia Clearance Study
Research Team
W
Weerawat Phuklia, PhD
E
Elizabeth Ashley
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here